INS and cardiovascular disorder: The inhibition of this signaling cascade impedes the glucose transport to the interior of the cells of insulin-dependent tissues (such as adipose, muscle and liver tissue), contributing to IR and subsequently to the development of T2D and cardiovascular diseases [55].